A study was conducted to determine the effect of mavacamten therapy on hospitalization and ED visit rates in patients with obstructive HCM.

Lexicon Pharmaceuticals targets a turnaround with sotagliflozin, LX9851, pilavapadin, and partnerships offering multiple ...

Three Late Breaking Science Presentations from MAPLE-HCM Provide Additional Data Including Responder Analyses, Patient Reported Outcomes, and ...

Cytokinetics' shares surge to a 52-week high as investor optimism grows over FDA approval prospects for aficamten.

In the Swedish Heart and Lung Foundation's latest call, research grants of SEK 20.3 million were awarded to ten researchers ...

Papillary muscle scarring (papSCAR) as detected by dark blood delayed-enhancement cardiovascular magnetic resonance (CMR) was ...

"Following standard angiography, microvascular angina was commonly misdiagnosed as noncardiac chest pain," he added. "Endotyping-informed therapy in the MRI-guided intervention group led to ...

If you’re old enough to remember Rosey on The Jetsons, there was a time when the thought of robots cleaning the baseboards around our homes or delivering dinner to our ...

Personalized vitamin D supplementation -- often requiring 5,000 IU of vitamin D each day -- did prove to have secondary ...

B. Riley analyst Mayank Mamtani raised the firm’s price target on Cytokinetics (CYTK) to $90 from $80 and keeps a Buy rating on the shares.

Chagas disease, or American trypanosomiasis, is one of the most important yet neglected parasitic infections in the world.